Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 33 | 33 | 34 | 35 | 35 |
| Accounts receivable | -84 | -4 | 38 | -59 | -9 |
| Other Working Capital | -88 | 84 | -241 | 88 | 147 |
| Other Operating Activity | -567 | -635 | -734 | -713 | -648 |
| Operating Cash Flow | $-706 | $-522 | $-902 | $-650 | $-475 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 550 | 635 | 1,000 | 770 | 500 |
| Debt Repayment | -42 | -42 | -40 | -39 | -39 |
| Financing Cash Flow | $508 | $594 | $960 | $731 | $461 |
| Beginning Cash Position | 242 | 170 | 112 | 30 | 44 |
| End Cash Position | 44 | 242 | 170 | 112 | 30 |
| Net Cash Flow | $-198 | $72 | $58 | $82 | $-14 |
| Free Cash Flow | |||||
| Operating Cash Flow | -706 | -522 | -902 | -650 | -475 |
| Free Cash Flow | -706 | -522 | -902 | -650 | -475 |